ALPS Medical Breakthroughs ETF (SBIO)
NYSEARCA: SBIO · Real-Time Price · USD
53.53
-0.08 (-0.15%)
At close: May 1, 2026, 4:00 PM EDT
53.53
0.00 (0.00%)
After-hours: May 1, 2026, 4:10 PM EDT
SBIO Holdings Information
SBIO is an equity ETF with a total of 87 individual holdings. The top holdings are Kymera Therapeutics stock at 4.14%, Mirum Pharmaceuticals at 3.68%, Spyre Therapeutics at 3.66%, CG Oncology at 3.53%, and Alkermes at 3.52%.
Total Holdings
87
Top 10 Percentage
33.69%
Asset Class
Equity
ETF Category
Health
Assets
152.33M
PE Ratio
n/a
Breakdown by Sector
Top 25 Holdings
| No. | Symbol | Name | % Weight |
|---|---|---|---|
| 1 | KYMR | Kymera Therapeutics, Inc. | 4.14% |
| 2 | MIRM | Mirum Pharmaceuticals, Inc. | 3.68% |
| 3 | SYRE | Spyre Therapeutics, Inc. | 3.66% |
| 4 | CGON | CG Oncology, Inc. | 3.53% |
| 5 | ALKS | Alkermes plc | 3.52% |
| 6 | CELC | Celcuity Inc. | 3.51% |
| 7 | APLS | Apellis Pharmaceuticals, Inc. | 3.28% |
| 8 | XENE | Xenon Pharmaceuticals Inc. | 2.92% |
| 9 | APGE | Apogee Therapeutics, Inc. | 2.91% |
| 10 | CRNX | Crinetics Pharmaceuticals, Inc. | 2.54% |
| 11 | DNTH | Dianthus Therapeutics, Inc. | 2.44% |
| 12 | TVTX | Travere Therapeutics, Inc. | 2.43% |
| 13 | ACAD | ACADIA Pharmaceuticals Inc. | 2.40% |
| 14 | VKTX | Viking Therapeutics, Inc. | 2.26% |
| 15 | EWTX | Edgewise Therapeutics, Inc. | 2.08% |
| 16 | ORKA | Oruka Therapeutics, Inc. | 2.07% |
| 17 | NAMS | NewAmsterdam Pharma Company N.V. | 2.06% |
| 18 | DNLI | Denali Therapeutics Inc. | 1.86% |
| 19 | GPCR | Structure Therapeutics Inc. | 1.84% |
| 20 | TARS | Tarsus Pharmaceuticals, Inc. | 1.69% |
| 21 | IDYA | IDEAYA Biosciences, Inc. | 1.60% |
| 22 | VERA | Vera Therapeutics, Inc. | 1.59% |
| 23 | IRON | Disc Medicine, Inc. | 1.58% |
| 24 | ZLAB | Zai Lab Limited | 1.51% |
| 25 | RLAY | Relay Therapeutics, Inc. | 1.45% |
As of Apr 30, 2026